Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
出版年份 2023 全文链接
标题
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study
作者
关键词
-
出版物
LANCET
Volume 401, Issue 10382, Pages 1091-1102
出版商
Elsevier BV
发表日期
2023-03-14
DOI
10.1016/s0140-6736(23)00085-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Fezolinetant in Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT
- (2023) Kimball A Johnson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN
- (2021) Rebecca C. Thurston et al. Journal of the American Heart Association
- Fezolinetant in the treatment of vasomotor symptoms associated with menopause
- (2021) Herman Depypere et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure
- (2020) Filip Milosavljevic et al. JAMA Psychiatry
- Treatment of Menopausal Vasomotor Symptoms with Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial
- (2019) Herman Depypere et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vasomotor Symptoms Across the Menopause Transition
- (2018) Nancy E. Avis et al. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- Moderate–Severe Vasomotor Symptoms Are Associated with Moderate–Severe Depressive Symptoms
- (2017) Roisin Worsley et al. JOURNAL OF WOMENS HEALTH
- Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial
- (2017) Julia K Prague et al. LANCET
- The 2017 hormone therapy position statement of The North American Menopause Society
- (2017) MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Nonhormonal management of menopause-associated vasomotor symptoms
- (2015) MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Risk of long-term hot flashes after natural menopause
- (2014) Ellen W. Freeman et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Menopause: Executive Summary of Recommendations
- (2013) Neil Goodman et al. Endocrine Practice
- Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: A novel hypothesis on the mechanism of hot flushes
- (2013) Naomi E. Rance et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms
- (2013) James A. Simon et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Methods for the design of vasomotor symptom trials
- (2013) Katherine M. Newton et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Vasomotor Symptoms and Menopause: Findings from the Study of Women's Health across the Nation
- (2011) Rebecca C. Thurston et al. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- Association of menopausal vasomotor symptoms with increased bone turnover during the menopausal transition
- (2010) Carolyn J Crandall et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life
- (2009) Rachel E. Williams et al. MATURITAS
- Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women
- (2009) Nancy E. Avis et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now